March 02, 2023
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
Media
March 01, 2023
Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 01, 2023
Hemab Therapeutics’ Statement Announcing the Planned Departure of Co-Founder and CTO Johan Faber
February 28, 2023
Year-end report 2022
February 27, 2023
Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock
February 22, 2023
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
HealthCap Portfolio Company Hemab Therapeutics raises $135M Series B Financing
February 21, 2023
Q4 2022 General Market Overview
February 16, 2023
BONESUPPORT HOLDING AB (publ) – publishes year-end report 2022
February 16, 2023
Oncopeptides publishes year-end report 2022